Cargando…

Association of glucose and blood pressure variability on oxidative stress in patients with type 2 diabetes mellitus and hypertension: a cross-sectional study

BACKGROUND: The present study evaluated the effects of glucose and blood pressure (BP) variability on oxidative stress in patients with type 2 diabetes mellitus (T2DM) and hypertension. METHODS: A total of 60 inpatients with T2DM underwent continuous glucose monitoring (CGM) and ambulatory BP monito...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohara, Makoto, Kohata, Yo, Nagaike, Hiroe, Koshibu, Masakazu, Gima, Hiroya, Hiromura, Munenori, Yamamoto, Takeshi, Mori, Yusaku, Hayashi, Toshiyuki, Fukui, Tomoyasu, Hirano, Tsutomu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460855/ https://www.ncbi.nlm.nih.gov/pubmed/31044019 http://dx.doi.org/10.1186/s13098-019-0425-y

Ejemplares similares

Effect of Dulaglutide Versus Liraglutide on Glucose Variability, Oxidative Stress, and Endothelial Function in Type 2 Diabetes: A Prospective Study
por: Nagaike, Hiroe, et al.
Publicado: (2019)

Pancreatic fat accumulation evaluated by multidetector computed tomography in patients with type 2 diabetes
por: Fukase, Ayako, et al.
Publicado: (2020)

Association of Hemoglobin A1c, 1,5-Anhydro-d-Glucitol and Glycated Albumin with Oxidative Stress in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study
por: Kohata, Yo, et al.
Publicado: (2020)

The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis
por: Kushima, Hideki, et al.
Publicado: (2017)

Glucose Variability is Independently Correlated with Serum Level of Pigment Epithelium-Derived Factor in Type 2 Diabetes
por: Fujikawa, Tomoki, et al.
Publicado: (2021)

Luseogliflozin attenuates neointimal hyperplasia after wire injury in high-fat diet-fed mice via inhibition of perivascular adipose tissue remodeling
por: Mori, Yusaku, et al.
Publicado: (2019)

Nesfatin-1 suppresses peripheral arterial remodeling without elevating blood pressure in mice
por: Mori, Yusaku, et al.
Publicado: (2019)

A Dipeptidyl Peptidase-4 Inhibitor Suppresses Macrophage Foam Cell Formation in Diabetic db/db Mice and Type 2 Diabetes Patients
por: Terasaki, Michishige, et al.
Publicado: (2018)

Circulating anti‐glutamic acid decarboxylase‐65 antibody titers are positively associated with the capacity of insulin secretion in acute‐onset type 1 diabetes with short duration in a Japanese population
por: Yamamura, So, et al.
Publicado: (2019)

Very rare case of Graves’ disease with resistance to methimazole: a case report and literature review
por: Mori, Yusaku, et al.
Publicado: (2021)

A Dipeptidyl Peptidase-4 Inhibitor Inhibits Foam Cell Formation of Macrophages in Type 1 Diabetes via Suppression of CD36 and ACAT-1 Expression
por: Terasaki, Michishige, et al.
Publicado: (2020)

Anti-inflammatory and atheroprotective properties of glucagon
por: Osaka, Naoya, et al.
Publicado: (2020)

Combination Therapy with a Sodium-Glucose Cotransporter 2 Inhibitor and a Dipeptidyl Peptidase-4 Inhibitor Additively Suppresses Macrophage Foam Cell Formation and Atherosclerosis in Diabetic Mice
por: Terasaki, Michishige, et al.
Publicado: (2017)

Comparison of positive rates between glutamic acid decarboxylase antibodies and ElisaRSR™ 3 Screen ICA™ in recently obtained sera from patients who had been previously diagnosed with slowly progressive type 1 diabetes
por: Takehana, Nobuaki, et al.
Publicado: (2023)

Luseogliflozin inhibits high glucose-induced TGF-β2 expression in mouse cardiomyocytes by suppressing NHE-1 activity
por: Osaka, Naoya, et al.
Publicado: (2022)

Glucose-dependent insulinotropic polypeptide inhibits cardiac hypertrophy and fibrosis in diabetic mice via suppression of TGF-β2
por: Hiromura, Munenori, et al.
Publicado: (2022)

Analysis of pancreatic volume in acute‐onset, slowly‐progressive and fulminant type 1 diabetes in a Japanese population
por: Sasamori, Hiroto, et al.
Publicado: (2018)

Prospective randomized comparative study of the effect of pemafibrate add‐on or double statin dose on small dense low‐density lipoprotein‐cholesterol in patients with type 2 diabetes and hypertriglyceridemia on statin therapy
por: Hirano, Tsutomu, et al.
Publicado: (2023)

Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin
por: Hayashi, Toshiyuki, et al.
Publicado: (2017)

Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin
por: Hayashi, Toshiyuki, et al.
Publicado: (2017)

Teneligliptin, a Dipeptidyl Peptidase-4 Inhibitor, Improves Early-Phase Insulin Secretion in Drug-Naïve Patients with Type 2 Diabetes
por: Ito, Rika, et al.
Publicado: (2015)

AGE-RAGE Axis Stimulates Oxidized LDL Uptake into Macrophages through Cyclin-Dependent Kinase 5-CD36 Pathway via Oxidative Stress Generation
por: Yashima, Hironori, et al.
Publicado: (2020)

Amelioration of Hyperglycemia with a Sodium-Glucose Cotransporter 2 Inhibitor Prevents Macrophage-Driven Atherosclerosis through Macrophage Foam Cell Formation Suppression in Type 1 and Type 2 Diabetic Mice
por: Terasaki, Michishige, et al.
Publicado: (2015)

Glucose-Dependent Insulinotropic Polypeptide Suppresses Foam Cell Formation of Macrophages through Inhibition of the Cyclin-Dependent Kinase 5-CD36 Pathway
por: Terasaki, Michishige, et al.
Publicado: (2021)

Circadian Rhythm of Subspecies of Low-Density Lipoprotein-Cholesterol and High-Density Lipoprotein-Cholesterol in Healthy Subjects and Patients with Type 2 Diabetes
por: Hayashi, Toshiyuki, et al.
Publicado: (2023)

Pheochromocytoma presenting with severe hyperglycemia and metabolic acidosis following intra-articular glucocorticoid administration: a case report
por: Tomoyasu, Masako, et al.
Publicado: (2019)

Anti‐atherogenic and anti‐inflammatory properties of glucagon‐like peptide‐1, glucose‐dependent insulinotropic polypepide, and dipeptidyl peptidase‐4 inhibitors in experimental animals
por: Hirano, Tsutomu, et al.
Publicado: (2016)

Type 1 diabetes patients have lower strength in femoral bone determined by quantitative computed tomography: A cross-sectional study
por: Ishikawa, Koji, et al.
Publicado: (2015)

SMTP-44D Inhibits Atherosclerotic Plaque Formation in Apolipoprotein-E Null Mice Partly by Suppressing the AGEs-RAGE Axis †
por: Terasaki, Michishige, et al.
Publicado: (2023)

GIP as a Potential Therapeutic Target for Atherosclerotic Cardiovascular Disease–A Systematic Review
por: Mori, Yusaku, et al.
Publicado: (2020)

Non-insulin-dependent Diabetes Mellitus Induced by Immune Checkpoint Inhibitor Therapy in an Insulinoma-associated Antigen-2 Autoantibody-positive Patient with Advanced Gastric Cancer
por: Ohara, Nobumasa, et al.
Publicado: (2019)

Six-month results of intravitreal ranibizumab for macular edema after branch retinal vein occlusion in a single-center prospective study: visual outcomes and microaneurysm formation
por: Kawamura, Mihoko, et al.
Publicado: (2018)

Bi-glandular and persistent enterovirus infection and distinct changes of the pancreas in slowly progressive type 1 diabetes mellitus
por: Fukui, Tomoyasu, et al.
Publicado: (2023)

Method for estimating high sdLDL-C by measuring triglyceride and apolipoprotein B levels
por: Hayashi, Toshiyuki, et al.
Publicado: (2017)

Microaneurysms cause refractory macular edema in branch retinal vein occlusion
por: Tomiyasu, Taneto, et al.
Publicado: (2016)

Occupational radiation exposure to the lens of the eyes and its protection during endoscopic retrograde cholangiopancreatography
por: Ikezawa, Kenji, et al.
Publicado: (2023)

Legumain Promotes Atherosclerotic Vascular Remodeling
por: Ozawa, Nana, et al.
Publicado: (2019)

Antiatherogenic Properties of Acetone Extract of Alpinia zerumbet Seeds
por: Chompoo, Jamnian, et al.
Publicado: (2012)

Nootropics with potential to (re)build neuroarchitecture
por: Koshibu, Kyoko
Publicado: (2016)

Adropin Contributes to Anti-Atherosclerosis by Suppressing Monocyte-Endothelial Cell Adhesion and Smooth Muscle Cell Proliferation
por: Sato, Kengo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_s3o8rk513d9agpun85ggqgv8ec